KNSA Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

$KNSA typical taps a 52 wk high and is sold down to 79. If this is as strong as it looks over last few weeks it was a last opportunity to get a decent price sub 80 of a breakout is real

$KNSA I may regret this lol but I sold 20% of my position as it was getting too big!Still super bullish and hold most of it with $28AVERAGE

$KNSA 🏥 Idorsia Pharmaceuticals Ltd will pursue a new development program for daridorexant 50 mg in autism spectrum disorder following unexpected improvements in affect and behavior in a Phase 2 pediatric insomnia study.

$KNSA 🏥 Idorsia presents positive clinical results for daridorexant in children and adolescents with insomnia, with a single 50 mg dose increasing sleep time by 50 minutes overall and 64 minutes in children with neurodevelopmental disorders. Market-relevant event

$KNSA Congrats to the few who held and believed in arcalyst over the last few years, what a banger

$KNSA has spent about 10 weeks building a base under its July high of 82.94, and Friday's 79.78 close was its best since early September. Sales jumped 55% last quarter and the company raised its full-year outlook. I want a push through 82.94 on strong volume, and with earnings due late this month I'm not in a rush.

Kiniksa Pharmaceuticals International made $73M over the past 12 months, after losing $17M the year before. Scores a 20, top 15 of 3,283 stocks. $KNSA